Extension Letter to International Assignment under Employment Agreement between Teva Pharmaceutical Industries Ltd. and Eric Drape

Summary

Teva Pharmaceutical Industries Ltd. and Eric Drape have agreed to extend Eric Drape's international assignment, originally set out in his Employment Agreement dated March 12, 2020, until January 1, 2025. All other terms and conditions of the original agreement remain unchanged during this extension period. Both parties have signed to confirm their acceptance of this extension.

EX-10.31 5 d443725dex1031.htm EX-10.31 EX-10.31

Exhibit 10.31

 

December 12, 2022

Private and confidential

To: Eric Drape

Subject: Extension letter to International Assignment as stated in Employment Agreement dated March 12, 2020 (the “Agreement”)

The parties mutually agree to extend the undersigned international assignment until January 1, 2025 (the “Extension Period”).

All terms and conditions under the Agreement will remain the same during the Extension Period.

Sincerely Yours,

 

/s/ Galia Inbar

Galia Inbar

Please indicate your agreement by signing below and returning this letter as soon as possible.

I have reviewed the terms of this Extension Period outlined above and by signing below, accept those terms.

 

Eric Drape

  

/s/ Eric Drape

  

Dec. 27, 2022

Name

  

Signature

  

Date

Teva Pharmaceutical Industries Ltd.

124 Dvora HaNevi’a St., Tel Aviv ###-###-#### Israel | www.tevapharm.com